OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
An OX-Tra’Ordinary Tale: The Role of OX40 and OX40L in Atopic Dermatitis
Kaviyon Sadrolashrafi, Lily Guo, Robin Kikuchi, et al.
Cells (2024) Vol. 13, Iss. 7, pp. 587-587
Open Access | Times Cited: 8
Kaviyon Sadrolashrafi, Lily Guo, Robin Kikuchi, et al.
Cells (2024) Vol. 13, Iss. 7, pp. 587-587
Open Access | Times Cited: 8
Showing 8 citing articles:
Update on the pathogenesis of atopic dermatitis
Paulo Ricardo Criado, Hélio Amante Miot, Roberto Bueno Filho, et al.
Anais Brasileiros de Dermatologia (2024) Vol. 99, Iss. 6, pp. 895-915
Open Access | Times Cited: 5
Paulo Ricardo Criado, Hélio Amante Miot, Roberto Bueno Filho, et al.
Anais Brasileiros de Dermatologia (2024) Vol. 99, Iss. 6, pp. 895-915
Open Access | Times Cited: 5
Generation and characterization of OX40-ligand fusion protein that agonizes OX40 on T-Lymphocytes
Ayaka Sato, Hodaka Nagai, Ayano Suzuki, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Ayaka Sato, Hodaka Nagai, Ayano Suzuki, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Emergency vs. Outpatient Care for Pediatric Atopic Dermatitis: A Population-Based Study of Sociodemographic Factors and Healthcare Utilization
Rebecca K. Yamamoto, Hannah C. Tolson, Audrey Hao, et al.
The Journal of Pediatrics (2025), pp. 114604-114604
Closed Access
Rebecca K. Yamamoto, Hannah C. Tolson, Audrey Hao, et al.
The Journal of Pediatrics (2025), pp. 114604-114604
Closed Access
Novel therapeutic receptor agonists and antagonists in allergic conjunctivitis
Sampson Listowell Abu, Navpreet K. Hehar, DeGaulle I. Chigbu
Current Opinion in Allergy and Clinical Immunology (2024) Vol. 24, Iss. 5, pp. 380-389
Closed Access | Times Cited: 2
Sampson Listowell Abu, Navpreet K. Hehar, DeGaulle I. Chigbu
Current Opinion in Allergy and Clinical Immunology (2024) Vol. 24, Iss. 5, pp. 380-389
Closed Access | Times Cited: 2
Race science without racists: how bigoted paradigms persist in allergy research
Ian A. Myles
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1
Ian A. Myles
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1
Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis
Stephan Weidinger, Andrew Blauvelt, Kim Papp, et al.
Journal of Allergy and Clinical Immunology (2024)
Open Access | Times Cited: 1
Stephan Weidinger, Andrew Blauvelt, Kim Papp, et al.
Journal of Allergy and Clinical Immunology (2024)
Open Access | Times Cited: 1
Biologic Brachytherapy: Genetically Modified Surgical Flap as a Therapeutic Tool—A Systematic Review of Animal Studies
Wiktor Pascal, Mateusz Gotowiec, Antoni Smoliński, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10330-10330
Open Access
Wiktor Pascal, Mateusz Gotowiec, Antoni Smoliński, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10330-10330
Open Access
Atualização na patogênese da dermatite atópica
Paulo Ricardo Criado, Hélio Amante Miot, Roberto Bueno Filho, et al.
(2024) Vol. 99, Iss. 6, pp. 895-915
Open Access
Paulo Ricardo Criado, Hélio Amante Miot, Roberto Bueno Filho, et al.
(2024) Vol. 99, Iss. 6, pp. 895-915
Open Access
